These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24003223)

  • 1. A brain-specific Grb2-associated regulator of extracellular signal-regulated kinase (Erk)/mitogen-activated protein kinase (MAPK) (GAREM) subtype, GAREM2, contributes to neurite outgrowth of neuroblastoma cells by regulating Erk signaling.
    Taniguchi T; Tanaka S; Ishii A; Watanabe M; Fujitani N; Sugeo A; Gotoh S; Ohta T; Hiyoshi M; Matsuzaki H; Sakai N; Konishi H
    J Biol Chem; 2013 Oct; 288(41):29934-42. PubMed ID: 24003223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the glycine-rich domain in GAREM2 on its unique subcellular localization upon EGF stimulation.
    Nishino T; Oshika T; Kyan M; Konishi H
    Cell Mol Biol Lett; 2021 Apr; 26(1):16. PubMed ID: 33931009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral analysis in mice deficient for GAREM2 (Grb2-associated regulator of Erk/MAPK subtype2) that is a subtype of highly expressing in the brain.
    Nishino T; Tamada K; Maeda A; Abe T; Kiyonari H; Funahashi Y; Kaibuchi K; Takumi T; Konishi H
    Mol Brain; 2019 Nov; 12(1):94. PubMed ID: 31718706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAREM, a novel adaptor protein for growth factor receptor-bound protein 2, contributes to cellular transformation through the activation of extracellular signal-regulated kinase signaling.
    Tashiro K; Tsunematsu T; Okubo H; Ohta T; Sano E; Yamauchi E; Taniguchi H; Konishi H
    J Biol Chem; 2009 Jul; 284(30):20206-14. PubMed ID: 19509291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional relationship between CABIT, SAM and 14-3-3 binding domains of GAREM1 that play a role in its subcellular localization.
    Nishino T; Matsunaga R; Konishi H
    Biochem Biophys Res Commun; 2015 Aug; 464(2):616-21. PubMed ID: 26164232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAREM1 is involved in controlling body mass in mice and humans.
    Nishino T; Abe T; Kaneko M; Yokohira M; Yamakawa K; Imaida K; Konishi H
    Biochem Biophys Res Commun; 2022 Nov; 628():91-97. PubMed ID: 36084556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The signaling adapter, FRS2, facilitates neuronal branching in primary cortical neurons via both Grb2- and Shp2-dependent mechanisms.
    Zhou L; Talebian A; Meakin SO
    J Mol Neurosci; 2015 Mar; 55(3):663-77. PubMed ID: 25159185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.
    Wills MK; Keyvani Chahi A; Lau HR; Tilak M; Guild BD; New LA; Lu P; Jacquet K; Meakin SO; Bisson N; Jones N
    J Biol Chem; 2017 Apr; 292(14):5748-5759. PubMed ID: 28213521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.
    Hanafusa H; Torii S; Yasunaga T; Nishida E
    Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
    Kim B; Cheng HL; Margolis B; Feldman EL
    J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
    Kim B; Leventhal PS; White MF; Feldman EL
    Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
    Vacca F; Bagnato A; Catt KJ; Tecce R
    Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. v-Crk modulation of growth factor-induced PC12 cell differentiation involves the Src homology 2 domain of v-Crk and sustained activation of the Ras/mitogen-activated protein kinase pathway.
    Teng KK; Lander H; Fajardo JE; Hanafusa H; Hempstead BL; Birge RB
    J Biol Chem; 1995 Sep; 270(35):20677-85. PubMed ID: 7657647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential utilization of ShcA tyrosine residues and functional domains in the transduction of epidermal growth factor-induced mitogen-activated protein kinase activation in 293T cells and nerve growth factor-induced neurite outgrowth in PC12 cells. Identification of a new Grb2.Sos1 binding site.
    Thomas D; Bradshaw RA
    J Biol Chem; 1997 Aug; 272(35):22293-9. PubMed ID: 9268379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
    Kang S; Dong S; Guo A; Ruan H; Lonial S; Khoury HJ; Gu TL; Chen J
    J Biol Chem; 2008 Feb; 283(8):4652-7. PubMed ID: 18156174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A MAP kinase-signaling pathway mediates neurite outgrowth on L1 and requires Src-dependent endocytosis.
    Schmid RS; Pruitt WM; Maness PF
    J Neurosci; 2000 Jun; 20(11):4177-88. PubMed ID: 10818153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells.
    Wu Y; Chen Y; Qu R; Lan T; Sang J
    Oncol Rep; 2012 Feb; 27(2):553-8. PubMed ID: 22012247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S; Hakuno F; Takahashi S
    Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway.
    Okada S; Kao AW; Ceresa BP; Blaikie P; Margolis B; Pessin JE
    J Biol Chem; 1997 Oct; 272(44):28042-9. PubMed ID: 9346957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.